Business · 10/04/2001Updated: 10/17/2026 · 1 min read
FDA Corrects Withdrawal of Approval for 14 New Drug Applications and 13 Abbreviated New Drug Applications
Summary
The FDA is correcting a notice that withdrew approval of 14 new drug applications and 13 abbreviated new drug applications, including one for Sulf-10, a sulfacetamide sodium ophthalmic solution, after realizing the mistake affected a specific application held by Ciba Vision.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →